Skip to content
Top Globe News – Lifestyle
Author:
Insight Molecular Diagnostics Inc.
iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
July 23, 2026
Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
July 16, 2026
IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper
June 29, 2026
iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant
June 22, 2026
Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry
June 16, 2026
IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation
June 11, 2026
iMDx to Highlight In-House Transplant Testing Opportunity and Host Key Opinion Leaders at American Transplant Congress
June 9, 2026
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
May 14, 2026
iMDx to Release First Quarter 2026 Results on May 13, 2026
May 6, 2026
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
April 14, 2026
1
2
Next Page
→